Search
for
Sort by
Research 481–510 of 1000+
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Licorice: A review on phytochemical insights and therapeutic potential
- Management of Telogen Effluvium: A Survey among Dermatologists and Dermatology Residents of Nepal
- Testosterone and female sexuality: A skeptical view
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Analysis of Female Pattern Hair loss
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- A case series of 20 women with hidradenitis suppurativa treated with spironolactone
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Green tea in dermatology - myths and facts
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- Current standards in the diagnostics and therapy of hair diseases - hair consultation
- Fibrosing Alopecia in a Pattern Distribution: A Case Report and Literature Review
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- The potential of androgenic alopecia management from plant derivatives
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia
- Dermatologic care of the transgender patient - eScholarship
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs